Polly names two of its compounding pharmacies and gives NAD+ two product pages of its own, each printing its figure on the page. What it never answers is what its figures recur on: no page attaches a billing period to a price, and the terms say the interval is disclosed inside a checkout that begins with an email gate.
What Polly charges
NAD+: $183 — printed bare as '$183' on the NAD+ vial product page with no billing period stated; the card tags the line 'Injectable' and 'Weekly', which are dosing tags rather than a billing cycle
NAD+: $199 — printed bare as '$199' on the NAD+ spray product page with no billing period stated
Sermorelin: $179 — printed as a bare '$179' badge on the home-page product card, with no billing period stated; the seller publishes no sermorelin product page, so this card is the only place the figure appears
Polly is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
The figures are published; the period is not
Both NAD+ formats have a product page carrying a bare figure, and the sermorelin figure appears as a badge on a home-page card. All three are published plainly and none of them is converted, divided or derived from anything else.
None of them carries a period. There is no per-month suffix, no billing note beside the number and no plan length stated anywhere on the pages that print them.
The word that appears closest to each figure is a dosing tag on the card, sitting beside the delivery format. It describes how often a dose is taken, not how often a card is charged, and treating it as a billing cycle would invent a rate the seller has never printed.
The terms confirm the gap rather than closing it: subscriptions are charged at regular intervals as described for that product during the checkout process. The interval exists, and it is disclosed after a reader has handed over an email address.
Reading the cards the right way round
The home page presents its catalogue as a row of cards, each holding a price badge, a product name and two small tags. Read as a flat run of text, the row is ambiguous: a figure could belong to the name before it or the name after it.
It belongs to the name after it. A single card captured on its own shows the badge sitting above the product name inside one bounded box, with the delivery and dosing tags below, and every card in the row is built the same way. Each card links to that product's own intake.
Read the other way, every figure in the row would have been attached to the wrong product and one card would have been left with no price at all. That is not a subtle error; it is the whole comparison, backwards.
This is why a figure here is judged by what a reader sees, not by where the markup happens to put it.
Named pharmacies, as examples
The FAQ asks which pharmacies the service uses and answers with two named compounding pharmacies. Both are real facilities a reader can look up, which is more than a licence class or an accreditation body.
The wording is deliberately open: the answer says the seller partners with licensed compounding pharmacies across the country, including pharmacies such as those two. That is a sample, not a roster, and this review treats it as one.
Nothing on the site says which pharmacy fills a given order, and the product pages say only that treatment ships from a licensed pharmacy. So a reader learns two names without learning whose name will be on their package.
The footer names the operating company behind the brand, and a dedicated page explains the rename from its former identity — both useful when a reader is trying to work out who they are buying from.
Coverage, inclusions and a missing product page
The FAQ asks which states the service is available in and answers with the whole country. The question is about this seller's availability and the answer is this seller's own, so it reads as a service-area claim rather than someone else's licensure being borrowed.
Each product page lists what a plan includes, item by item: a provider review, the treatment if approved, ongoing support, shipping and supplies. Laboratory work is not among them and no lab appears anywhere on the site.
There is no sermorelin product page. The path where one would sit returns the site's own not-found document, and the sermorelin card links straight into an intake instead. The figure on that card is the only place the sermorelin price is published.
No line states a dose or a concentration, so as with the billing period, a reader comparing this seller against another is comparing a plan to a plan rather than a quantity to a quantity.
Who it's for
Readers who want compounding pharmacies named rather than described by licence class.
Buyers choosing between two NAD+ delivery formats, each with its own product page.
Shoppers who want the operating company behind the brand published, along with an explanation of its rename.
Anyone who wants a plain, itemised list of what a plan covers.
Readers who will ask what a figure recurs on before committing to it.
Who should look elsewhere
Buyers who need a comparable monthly rate, since no figure here carries a stated billing period.
Readers unwilling to hand over an email address to learn the billing interval.
Anyone who wants a sermorelin product page rather than a home-page card and an intake link.
Shoppers who need to know which specific pharmacy will fill their order.
Buyers who expect laboratory work in the price, or who compare dose for dose.
Readers looking for GHK-Cu, tesamorelin, glutathione, PT-141 or any tracked compound beyond sermorelin and NAD+.
Strengths
Names two of its compounding pharmacies in a public FAQ answer rather than describing them generically
Gives each NAD+ format its own product page with the figure printed on it
Answers its own state-coverage question directly on the home page
Says on each product page what the plan includes, item by item
Publishes the operating entity behind the brand and a page explaining its rename
Trade-offs
Attaches no billing period to any published figure, so none of its prices can be compared as a monthly rate
Its terms disclose the billing interval only inside a checkout behind an email gate
Publishes no sermorelin product page; that figure appears only on a home-page card
Names its pharmacies as examples rather than as a complete list, and names none for a given order
Includes no lab work and states no dose on any line
How we verified this
Rendered every page in a browser and read each figure from the rendered document rather than from served markup.
Captured a single product card on its own and confirmed from the image that the price badge sits above the product name inside one bounded box, rather than inferring the pairing from the order of the markup.
Confirmed each card links to that product's own intake, so the pairing is corroborated by where the card sends a reader as well as by how it looks.
Fired a nonsense path in the same run and confirmed the host answers it with its own short not-found document, distinct in length and content from every real product page.
Used that same not-found document to establish that no sermorelin product page exists, rather than assuming its absence from the sitemap.
Took the two NAD+ paths from the seller's own sitemap and product menu, and confirmed each rendered its own page before reading a figure from it.
Searched every product page, the terms, the refund policy and the shipping page for a billing period attached to any figure, and found the interval described only as something disclosed during checkout.
Opened the intake behind two of the product links and confirmed it begins with an email gate, then stopped rather than creating an account, so the interval remains unpublished for the purposes of this record.
Read the pharmacy FAQ answer in full and recorded its own hedging wording, so the two names are stored as examples rather than as a complete list.
Read the plan-inclusion list on the product pages and searched the site for any laboratory mention, finding none.
Searched the published federal warning-letter record under the operating entity from the footer and under the brand's domain-style name, having first proved the parser on a company whose letter is known to be in that record and on a nonsense term in the same run, and found no letter. The bare brand name was not searched, because a single common word over-matches that record and returns letters belonging to other firms.
A provider to compare Polly against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
The seller does not say. No page attaches a billing period to any figure, and its terms say the interval is described during the checkout process. This site records the figures without a period rather than assuming one.
Does the word on the product card tell you the billing cycle?
No. It is a dosing tag sitting beside the delivery format on the card, describing how often a dose is taken. It is not a billing term and is not treated as one here.
Which pharmacies does it use?
Its FAQ names two compounding pharmacies as examples, in an answer that explicitly describes a wider set. Nothing on the site says which one fills a given order.
Is there a sermorelin product page?
No. The path where one would sit returns the site's own not-found page, and the sermorelin card links directly into an intake. The card badge is the only published sermorelin figure.
Is laboratory work included?
No. The itemised plan inclusions are a provider review, the treatment if approved, ongoing support, shipping and supplies. No laboratory work is mentioned anywhere on the site.
Polly is not a paid partner; this link may earn a commission if that changes. Full disclosure.